Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1

Conditions

Multiple Myeloma 420Precursor Cell Lymphoblastic Leukemia-Lymphoma 126Neoplasms, Plasma Cell 74Recurrence 70Lymphoma 57Leukemia 54Neoplasms 46Immunoglobulin Light-chain Amyloidosis 38Burkitt Lymphoma 37Vomiting 36Lymphoma, Mantle-Cell 32Lymphoma, Large B-Cell, Diffuse 31Nausea 29Lymphoma, Non-Hodgkin 28Breast Neoplasms 22Waldenstrom Macroglobulinemia 21Lymphoma, Follicular 21Hodgkin Disease 21Leukemia, Lymphocytic, Chronic, B-Cell 20Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17Neoplasm Metastasis 17Prostatic Neoplasms 16Lymphoma, Extranodal NK-T-Cell 16Amyloidosis 16Leukemia, Myeloid, Acute 15Smoldering Multiple Myeloma 14Lymphoma, B-Cell, Marginal Zone 13Lung Neoplasms 11Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma, B-Cell 10

Interventions

Cisplatin 24Gemcitabine 16Radiotherapy, Intensity-Modulated 14Fluorouracil 7Radiotherapy 5Docetaxel 5pembrolizumab 4Surveys and Questionnaires 4Carboplatin 4Bevacizumab 4toripalimab 3spartalizumab 3camrelizumab 3Induction Chemotherapy 3Endostatins 3Counseling 3Cetuximab 3Acupuncture Therapy 3sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Psychiatric Rehabilitation 2Paclitaxel 2Nivolumab 2Immunohistochemistry 2Drug Therapy 2Chemoradiotherapy 2Celecoxib 2Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nasopharyngeal Neoplasms × Dexamethasone × Clear all
NCT05564286 2024-02-06

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Shantou University Medical College

Phase 3 Completed
116 enrolled
GynecologicHead & Neck

Uterine Cervical Neoplasms, Nasopharyngeal Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡